Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-084026

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 4, 2015
Accepted (ET)
Dec 8, 2015 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF4,F5Dec 4, 2015S70,990$14.5394D141,980ISee Note 5
Common StockF6,F5Dec 7, 2015S71,067$14.3835D70,913ISee Note 5
Common StockF7,F5Dec 8, 2015S70,913$14.7498D0ISee Note 5
Common Stockholding———115,355D
Common StockF1holding———57,678ISee Note 1
Common StockF2holding———33,360ISee Note 2
Common StockF3holding———24,317ISee Note 3

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses